Accelerated cell culture process development and characterization for cilgavimab/tixagevimab (AZD7442) for the prevention and treatment of COVID-19.
Handlogten MW, Bosley S, Dunn S, Zhu J, Lee-O'Brien A, Li L, Therres J, Chakrabarti L, Khanal B, Mowery R, Arumugam S, Klover J, Taleb M, Reier J, Hatton D, Schmelzer A.
Handlogten MW, et al. Among authors: li l.
Biotechnol Bioeng. 2023 Feb 1. doi: 10.1002/bit.28336. Online ahead of print.
Biotechnol Bioeng. 2023.
PMID: 36722717